| 2024 | Jucker M and Walker LC: Evidence for iatrogenic transmission of Alzheimer's disease. In: Nature Medicine, 30, 2024, 344-345 |
|---|
| 2024 | Lary C Walker and Mathias Jucker: The prion principle and Alzheimer's disease. In: Science, 385, 2024, 1278-1279 |
|---|
| 2023 | Jucker M and Walker LC: Alzheimer's disease: From immunotherapy to immunoprevention. In: Cell, 186, 2023, 4260-4270 |
|---|
| 2022 | Rother C, Uhlmann RE, Müller SA, Schelle J, Skodras A, Obermüller U, Häsler LM, Lambert M, Baumann F, Xu Y, Bergmann C, Salvadori G, Loos M, Brzak I, Shimshek D, Neumann U; Dominantly Inherited Alzheimer Network, Walker LC, Schultz SA, Chhatwal JP, Kaeser SA, Lichtenthaler SF, Staufenbiel M, Jucker M. Experimental evidence for temporal uncoupling of brain Aβ deposition and neurodegenerative sequelae. In: Nature Communications, 13, 2022, 7333 |
|---|
| 2022 | Wagner J, Degenhardt K, Veit M, Louros N, Konstantoulea K, Skodras A, Wild K, Liu P, Obermüller U, Bansal V, Dalmia A, Häsler LM, Lambert M, De Vleeschouwer M, Davies HA, Madine J, Kronenberg-Versteeg D, Feederle R, Del Turco D, Nilsson KPR, Lashley T, Deller T, Gearing M, Walker LC, Heutink P, Rousseau F, Schymkowitz J, Jucker M, Neher JJ: Medin co-aggregates with vascular amyloid-β in Alzheimer's disease. In: Nature, 612, 2022, 123-131 |
|---|
| 2020 | Uhlmann RE, Rother C, Rasmussen J, Schelle J, Bergmann C, Ullrich Gavilanes EM, Fritschi SK, Buehler A, Baumann F, Skodras A, Al-Shaana R, Beschorner N, Ye L, Kaeser SA, Obermüller U, Christensen S, Kartberg F, Stavenhagen JB, Rahfeld JU, Cynis H, Qian F, Weinreb PH, Bussiere T, Walker LC, Staufenbiel M, Jucker M: Acute targeting of pre-amyloid seeds in transgenic mice reduces Alzheimer-like pathology later in life. In: Nature Neuroscience, 23, 2020, 1580-1588 |
|---|
| 2020 | Walker LC: Aβ plaques. In: Free Neuropathology, 1, 2020, |
|---|
| 2018 | Walker LC, Lynn DG and Chernoff YO: A standard model of Alzheimer's disease?. In: Prion, 2018, 1-5 |
|---|
| 2018 | Walker LC: Prion-like mechanisms in Alzheimer disease. In: Maurizio Pocchiari, Jean Manson, Human Prion Diseases,
Handbook of Clinical Neurology, Vol 153 (3rd series). Elsevier, 2018. 303-319 |
|---|
| 2018 | Walker, LC: Prion-like protein seeding and the pathobiology of Alzheimer's disease. In: J Ghiso, A Rostagno, Protein Folding Disorders in the Central Nervous System. World Scientific, 2018. 57-82 |
|---|
| 2018 | Jucker M and Walker LC: Propagation and spread of pathogenic protein assemblies in neurodegenerative diseases.. In: Nature Neuroscience, 2018, 1341-1349 |
|---|
| 2017 | Ye L, Rasmussen J, Kaeser SA, Marzesco AM, Obermuller U, Mahler J, Schelle J, Odenthal J, Kruger C, Fritschi SK, Walker LC, Staufenbiel M, Baumann F and Jucker M.: A? seeding potency peaks in the early stages of cerebral ?-amyloidosis . In: EMBO Reports, 2017, 1536-1544 |
|---|
| 2017 | Rasmussen J, Jucker M and Walker LC: ABeta Seeds and Prions: How Close the Fit? . In: Prion, 2017, 215-225 |
|---|
| 2017 | Rasmussen J, Mahler J, Beschorner N, Kaeser SA, Häsler LM, Baumann F, Nyström S, Portelius E, Blennow K, Lashley T, Fox NC, Sepulveda-Falla D, Glatzel M, Oblak AL, Ghetti B, Nilsson KPR, Hammarström P, Staufenbiel M, Walker LC and Jucker M.: Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's disease. In: Proc Natl Acad Sci U S A, 2017, 13018-13023 |
|---|
| 2017 | Walker LC and Jucker M. The Exceptional Vulnerability of Humans to Alzheimer's Disease. In: Trends in Molecular Medicine, 2017, 534-545 |
|---|
| 2016 | Walker LC Proteopathic strains and the heterogeneity of neurodegenerative diseases. In: Annual Review of Genetics, 2016, 329-346 |
|---|